Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Moingeon

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Expert Review of Proteomics|December 23, 2021
Proteomics in support of immunotherapy: contribution to model-based precision medicineEmmanuel Nony, Philippe Moingeon
FEBS Open Bio|March 24, 2026
Digital twins to accelerate target identification and drug development for immune-mediated disordersAnna Niarakis, Philippe Moingeon
Seminars in Immunology|August 2, 2017
Differences and similarities between sublingual immunotherapy of allergy and oral tolerancePhilippe Moingeon, Laurent Mascarell
Expert Review of Clinical Immunology|January 28, 2016
Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North AmericaPhilippe Moingeon, Linda Cox
Clinical & Developmental Immunology|November 24, 2011
Induction of tolerance via the sublingual route: mechanisms and applicationsPhilippe Moingeon, Laurent Mascarell
Trends in Immunology|March 30, 2002
Challenges and issues in new vaccine developmentPhilippe Moingeon, Claude Leclerc
Expert Review of Clinical Immunology|January 21, 2023
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promisesLaurence Laigle, Loubna Chadli, Philippe Moingeon
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 30, 2004
Immunological foundations to the quest for new vaccine adjuvantsNicolas Burdin, Bruno Guy, Philippe Moingeon
Drug Discovery Today|September 23, 2021
Artificial intelligence-enhanced drug design and development: Toward a computational precision medicinePhilippe Moingeon, Mélaine Kuenemann, Mickaël Guedj
Immunology and Allergy Clinics of North America|May 17, 2006
Novel ways for immune intervention in immunotherapy: mucosal allergy vaccinesLaurent Mascarell, Laurence Van Overtvelt, Philippe Moingeon
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Expert Review of Proteomics|December 23, 2021
Proteomics in support of immunotherapy: contribution to model-based precision medicineEmmanuel Nony, Philippe Moingeon
FEBS Open Bio|March 24, 2026
Digital twins to accelerate target identification and drug development for immune-mediated disordersAnna Niarakis, Philippe Moingeon
Seminars in Immunology|August 2, 2017
Differences and similarities between sublingual immunotherapy of allergy and oral tolerancePhilippe Moingeon, Laurent Mascarell
Expert Review of Clinical Immunology|January 28, 2016
Relevance of a 5-grass sublingual tablet for immunotherapy of patients with grass pollen allergy in North AmericaPhilippe Moingeon, Linda Cox
Clinical & Developmental Immunology|November 24, 2011
Induction of tolerance via the sublingual route: mechanisms and applicationsPhilippe Moingeon, Laurent Mascarell
Trends in Immunology|March 30, 2002
Challenges and issues in new vaccine developmentPhilippe Moingeon, Claude Leclerc
Expert Review of Clinical Immunology|January 21, 2023
Biomarker-driven development of new therapies for autoimmune diseases: current status and future promisesLaurence Laigle, Loubna Chadli, Philippe Moingeon
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|March 30, 2004
Immunological foundations to the quest for new vaccine adjuvantsNicolas Burdin, Bruno Guy, Philippe Moingeon
Drug Discovery Today|September 23, 2021
Artificial intelligence-enhanced drug design and development: Toward a computational precision medicinePhilippe Moingeon, Mélaine Kuenemann, Mickaël Guedj
Immunology and Allergy Clinics of North America|May 17, 2006
Novel ways for immune intervention in immunotherapy: mucosal allergy vaccinesLaurent Mascarell, Laurence Van Overtvelt, Philippe Moingeon
Pageof 12